Myocardial oxygen consumption in left ventricular hypertrophy and its relation to left ventricular mechanics. 1983

W K Laskey, and N Reichek, and M St John Sutton, and W J Untereker, and J W Hirshfeld

Alterations in left ventricular (LV) mechanics have significant effects on myocardial oxygen consumption (MVO2) as a result of changing LV pressure and dimensions. However, the effects of load alteration on MVO2 in the setting of LV hypertrophy and LV dysfunction have not been well characterized. Therefore, we examined changes in LV mechanics and MVO2 in 32 patients with varying degrees of LV hypertrophy and LV dysfunction before and after pharmacologic alteration of load. With phenylephrine or nitroglycerin-induced load alteration, changes in peak systolic meridional stress, mean systolic stress and the area of a stress-dimension loop all correlated modestly with changes in MVO2 (r = 0.66, 0.62, 0.63, respectively). However, changes in the time integral of LV ejection stress, or shortening load, were significantly correlated with changes in MVO2 (r = 0.88, p less than 0.001). In particular, load reduction results in a beneficial effect on MVO2. In addition, for a given change in LV systolic pressure, changes in shortening load (38 +/- 3.7%) were significantly greater than changes in tension-time index (13 +/- 1.4%), thus providing a sensitive marker of alteration of mechanical load. We conclude that physiologic alterations in mechanical load in normal persons as well as patients with LV hypertrophy are reflected in significant changes in the time integral of LV ejection stress. These changes in shortening load, mediated by changing LV pressure and dimension, are significantly related to changes in MVO2.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D005260 Female Females
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006332 Cardiomegaly Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES. Cardiac Hypertrophy,Enlarged Heart,Heart Hypertrophy,Heart Enlargement,Cardiac Hypertrophies,Enlargement, Heart,Heart Hypertrophies,Heart, Enlarged,Hypertrophies, Cardiac,Hypertrophies, Heart,Hypertrophy, Cardiac,Hypertrophy, Heart

Related Publications

W K Laskey, and N Reichek, and M St John Sutton, and W J Untereker, and J W Hirshfeld
March 1972, Zeitschrift fur Kreislaufforschung,
W K Laskey, and N Reichek, and M St John Sutton, and W J Untereker, and J W Hirshfeld
July 1991, Harefuah,
W K Laskey, and N Reichek, and M St John Sutton, and W J Untereker, and J W Hirshfeld
November 1969, The American journal of physiology,
W K Laskey, and N Reichek, and M St John Sutton, and W J Untereker, and J W Hirshfeld
April 1977, Kokyu to junkan. Respiration & circulation,
W K Laskey, and N Reichek, and M St John Sutton, and W J Untereker, and J W Hirshfeld
January 1991, Basic research in cardiology,
W K Laskey, and N Reichek, and M St John Sutton, and W J Untereker, and J W Hirshfeld
September 1992, The Journal of thoracic and cardiovascular surgery,
W K Laskey, and N Reichek, and M St John Sutton, and W J Untereker, and J W Hirshfeld
April 1990, Journal of the American College of Cardiology,
W K Laskey, and N Reichek, and M St John Sutton, and W J Untereker, and J W Hirshfeld
January 1990, Basic research in cardiology,
W K Laskey, and N Reichek, and M St John Sutton, and W J Untereker, and J W Hirshfeld
October 1979, The American journal of cardiology,
W K Laskey, and N Reichek, and M St John Sutton, and W J Untereker, and J W Hirshfeld
July 1973, The American journal of physiology,
Copied contents to your clipboard!